Scientific Commons: A. N.

Trabalho apresentado no II Colóquio Brasil-Estados Unidos de Ciências da Comunicação, evento componente do XXVIII Congresso Brasileiro de Ciências da...

O papel do Relações Públicas na Gestão para a Qualidade Total (2005)

CARDIA,
A.N

Trabalho apresentado no NP 05 - Relações Públicas e Comunicação Organizacional no XXVII Congresso Brasileiro de Ciências da Comunicação, Porto...

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. (2005)

Phillips,
A.N.,
Dunn,
D.,
Sabin,
C.,
...

Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. (2005)

Sebire,
G.,
Tabarki,
B.,
Saunders,
D.E.,
...

Neuroimaging and management advances require review of indications for excluding cerebral venous sinus (sinovenous) thrombosis (CSVT) in children. Our goals were to examine (i) clinical presentations...

Cerebral venus sinus thrombosis in children: risk factors, presentation, diagnosis and outcome (2005)

Sebire,
G.,
Tabarki,
B.,
Saunders,
D.E.,
...

Neuroimaging and management advances require review of indications for excluding cerebral venous sinus (sinovenous) thrombosis (CSVT) in children. Our goals were to examine (i) clinical presentations...

The pediatric rheumatology international trials organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus - Prospective validation of the disease activity core set (2005)

Ruperto,
N.,
Ravelli,
A.,
Cuttica,
R.,
...

Objective. To validate and promulgate a core set of outcome measures for the evaluation of response to treatment in patients with juvenile systemic lupus erythematosus (SLE). Methods. In 2001, a...

The impact of telomere erosion on memory CD8(+) T cells in patients with X-linked lymphoproliferative syndrome (2005)

Plunkett,
F.J.,
Franzese,
O.,
Belaramani,
L.L.,
...

Patients with X-linked lymphoproliferative syndrome (XLP) experience excessive T cell proliferation after primary Epstein-Barr virus (EBV) infection, due to mutations in the signalling lymphocyte...

The effect of carbon dioxide on systemic oxygenation, oxygen consumption and blood lactate levels after the bidirectional superior cavopulmonary anastomosis (2005)

Li,
J.,
Hoskote,
A.,
Hickey,
C.,
...

Overview of ovarian cancer screening (2005)

Jacobs,
I.J.,
Rosenthal,
A.N.

Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice. (2005)

Phillips,
A.N.,
Dunn,
D.,
Sabin,
C.,
...

Overview of ovarian cancer screening (2005)

Jacobs,
I.J.,
Rosenthal,
A.N.

Hybridisation timing and shear strength of indirect resin-bonded restorations (2004)

Soszko,
J.B.,
Croysdill,
A.H.,
Stokes,
A.N.,
...

ADC changes with temperature in neonatal porcine brain. (2004)

Priest,
A.N.,
Bainbridge,
A.,
Thornton,
J.S.,
...

FAIR perfusion measurements in the neonatal piglet. (2004)

Priest,
A.N.,
Bainbridge,
A.,
Thornton,
J.S.,
...

Non-invasive regional cerebral thermometry by magnetic resonance spectroscopic imaging. (2004)

Thornton,
J.S.,
Cady,
E.B.,
Bainbridge,
A.,
...

6th-8th September

Determinants of survival following HIV-1 seroconversion after the introduction of HAART (2003)

Porter,
K.,
Babiker,
A.,
Bhaskaran,
K.,
...

Virological rebound after suppression on highly active antiretroviral therapy (2003)

Mocroft,
A.,
Ruiz,
L.,
Reiss,
P.,
...

OBJECTIVE To determine the rate of virological rebound and factors associated with rebound among patients on highly active antiretroviral therapy (HAART) with previously undetectable levels of...

Decline in the AIDS and death rates in the EuroSIDA study: an observational study (2003)

Mocroft,
A.,
Ledergerber,
B.,
Katlama,
C.,
...

BACKGROUND: Since the introduction of highly active antiretroviral therapy (HAART), little is known about whether changes in HIV-1 mortality and morbidity rates have been sustained. We aimed to...

The potential for CD4 cell increases in HIV-positive individuals who control viraemia with highly active antiretroviral therapy (2003)

Smith,
C.J.,
Sabin,
C.A.,
Lampe,
F.C.,
...

OBJECTIVES: To study the long-term CD4 cell responses to highly active antiretroviral therapy (HAART) in treatment-naive patients whose viral loads remained below 500 copies/ml for prolonged periods....

An audit of antiretroviral treatment use in HIV-infected patients in a London clinic: the limitations of observational databases when auditing antiretroviral treatment use (2003)

Sabin,
C.A.,
Lampe,
F.C.,
Chaloner,
C.,
...

OBJECTIVE: To audit the use of antiretroviral (ARV) treatment in a large treatment clinic in the UK against the British HIV Association (BHIVA) ARV treatment guidelines. METHODS: All patients under...

When should antiretroviral therapy be started for HIV infection? Interpreting the evidence from observational studies (2003)

Phillips,
A.N.,
Cozzi-Lepri,
A.C.,
Lampe,
F.,
...

Theoretical rationale for the use of sequential single-drug antiretroviral therapy for treatment of HIV infection (2003)

Phillips,
A.N.,
Youle,
M.S.,
Lampe,
F.,
...

BACKGROUND: Subpopulations of HIV with mutations associated with resistance to antiretroviral drugs often have reduced replicative capacity, so virus with resistance mutations for all existing and...

Viral breakthrough after suppression with highly active antiretroviral therapy: experience from 233 individuals with viral loads of less than 50 copies/ml followed for up to 4 years (2003)

Lampe,
F.C.,
Johnson,
M.A.,
Lipman,
M.,
...

Combination antiretroviral therapy and the risk of myocardial infarction (2003)

Friis-Moller,
N.,
Sabin,
C.A.,
Weber,
R.,
...

BACKGROUND: It remains controversial whether exposure to combination antiretroviral treatment increases the risk of myocardial infarction. METHODS: In this prospective observational study, we...

Dentinal crack incidence following ultrasonic vibration to intraradicular posts (2003)

Satterthwaite,
J.D.,
Pretty,
I.A.,
Stokes,
A.N.

2561

Early 1H spectroscopy and brain water T2 in encephalopathic infants (2003)

Shanmugalingam,
S.,
Thornton,
J.,
Cady,
E.,
...

Influence of flowable liner and margin location on microleakage of conventional and packable Class II composite resins (2003)

Tredwin,
C.J.,
Stokes,
A.N.

1971

Right ventricular myocardial responses to chronic pulmonary regurgitation (2003)

Gray,
R.P.,
Greve,
G.,
Chen,
R.,
...

Issued patent for Nav1.8 as an analgesic drug target ,in US, Japan, Australia CT/GB96/01523P (Publication no WO97/01577) Now issued in US (US6451554) (2003)

Wood,
J.N.,
Akopian,
A.N.

Proton-MRS of transient cerebral hypoxia in a chicken embryo model of fetal growth restriction (2003)

Thornton,
J.,
Dixon,
J.C.,
Priest,
A.N.,
...

Automatic determination of relative peak positions in non-water-suppressed proton spectra for cerebral temperature mapping by spectroscopic imaging (2003)

Thornton,
J.,
Cady,
E.,
Bainbridge,
A.,
...

10-16 July

Association between offspring birth weight and atherosclerosis in middle aged men and women: British Regional Heart Study (2003)

Lawlor,
D.A.,
Davey-Smith,
G.,
Whincup,
P.,
...

Impact of tuberculosis on HIV disease progression in persons with well-documented time of HIV seroconversion (2003)

CASCADE Collaboration,
Johnson,
A.M.,
Phillips,
A.N.

Association of virus load, CD4 cell count, and treatment with clinical progression in human immunodeficiency virus-infected patients with very low CD4 cell counts (2002)

Miller,
V.,
Phillips,
A.N.,
Clotet,
B.,
...

This study prospectively assessed the impact of treatment modality, virus load, and CD4 cell count of <50 cells/mm(3) on human immunodeficiency virus disease progression. The incidence rate of new...

A clinically prognostic scoring system for patients receiving highly active antiretroviral therapy: results from the EuroSIDA study (2002)

Lundgren,
J.D.,
Mocroft,
A.,
Gatell,
J.M.,
...

The risk of clinical progression for human immunodeficiency virus (HIV)-infected persons receiving treatment with highly active antiretroviral therapy (HAART) is poorly defined. From an inception...

Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study (2002)

Mocroft,
A.,
Phillips,
A.N.,
Friis-Moller,
N.,
...

There is an increasing proportion of HIV-positive patients exposed to all licensed classes of antiretrovirals, and the response to salvage regimens may be poor. Among over 8500 patients in EuroSIDA,...

Brief report: two-year outcome of a multidrug regimen in patients who did not respond to a protease inhibitor regimen (2002)

Youle,
M.,
Tyrer,
M.,
Fisher,
M.,
...

In most studies, people who have not responded virologically to a protease inhibitor (PI)-containing regimen have tended to experience poor virologic responses to subsequent regimens. We describe the...

Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression (2002)

Phillips,
A.N.,
Staszewski,
S.,
Lampe,
F.,
...

This study evaluated 1433 human immunodeficiency virus (HIV)-infected patients starting highly active antiretroviral therapy (HAART), 409 (28%) of whom had prior nucleoside experience and achieved an...

CD4 cell count changes in individuals with counts above 500 cells/mm and viral loads below 50 copies/ml on antiretroviral therapy (2002)

Phillips,
A.N.,
Youle,
M.,
Lampe,
F.,
...

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study (2002)

Matthews,
G.V.,
Sabin,
C.A.,
Mandalia,
S.,
...

BACKGROUND: Guidelines recommend both protease inhibitor (PI)- and non-nucleoside reverse transcriptase inhibitor (NNRTI)-containing regimens for initial therapy in HIV-positive individuals whilst...

Reduced bone mineral density in HIV-positive individuals (2001)

Moore,
A.L.,
Vashisht,
A.,
Sabin,
C.A.,
...

A total of 105 HIV-positive patients underwent dual-energy X-ray absorbtiometry (DEXA) scan to assess bone mineral density (BMD). The prevalence of reduced BMD was found to be 71% and was higher in...

Gender differences in virologic response to treatment in an HIV- positive population: a cohort study (2001)

Moore,
A.L.,
Mocroft,
A.,
Madge,
S.,
...

OBJECTIVE: To establish whether a gender difference in virologic response to highly active antiretroviral treatment (HAART) exists. METHODS: A cohort of HIV-positive individuals was examined....

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre (2001)

Mocroft,
A.,
Youle,
M.,
Moore,
A.,
...

OBJECTIVE: To describe the reasons for, and factors associated with, modification and discontinuation of highly active antiretroviral therapy (HAART) regimens at a single clinic. SUBJECTS: A total of...

The use of and response to second-line protease inhibitor regimens: results from the EuroSIDA study (2001)

Mocroft,
A.,
Phillips,
A.N.,
Miller,
V.,
...

OBJECTIVE: To describe the use of second line protease-inhibitor (PI) regimens across Europe and to determine factors associated with virological and immunological response. DESIGN: Analysis of data...

Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir (2001)

Kirk,
O.,
Mocroft,
A.,
Pradier,
C.,
...

OBJECTIVE: To compare the clinical response among patients who initiate protease inhibitor therapies with different virological potency. DESIGN: We analysed patients who started indinavir, ritonavir...

How the brain perceives casuality: an event-related fMRI study. (2001)

Blakemore,
S-J.,
Fonlupt,
P.,
Pachot,
M.,
...

Validation and utility of novel volume reduction technique for determination of parallel conductance (2001)

White,
P.A.,
Brookes,
C.I.,
Ravn,
H.,
...

The flow cytometric analysis of telomere length in antigen- specific CD8(+) T cells during acute Epstein-Barr virus infection (2001)

Plunkett,
F.J.,
Soares,
M.V.D.,
Annels,
N.,
...

Acute infectious mononucleosis (AIM) induced by Epstein-Barr virus (EBV) infection is characterized by extensive expansion of antigen specific CD8(+) T cells. One potential consequence of this...

Course of viral load throughout HIV-1 infection (2000)

Sabin,
C.A.,
Devereux,
H.,
Phillips,
A.N.,
...

HIV-1 RNA levels are routinely monitored as part of patient management. However, little is known about the course of HIV-1 RNA levels over the entire period of infection. The aim of this study was to...

Course of viral load throughout HIV-1 infection (2000)

Sabin,
C.A.,
Devereux,
H.,
Phillips,
A.N.,
...

HIV-1 RNA levels are routinely monitored as part of patient management. However, little is known about the course of HIV-1 RNA levels over the entire period of infection. The aim of this study was to...

The inhibition of cutaneous T cell apoptosis may prevent resolution of inflammation in atopic eczema (2000)

Orteu,
C.H.,
Rustin,
M.H.A.,
O'Toole,
E.,
...

Atopic eczema (AE) is characterized by the persistence of infiltrating T lymphocytes in the dermis. To test the hypothesis that dysregulation of normal T cell apoptosis may contribute to the...

Cytomegalovirus seropositivity and human immunodeficiency virus type 1 RNA levels in individuals with hemophilia (2000)

Sabin,
C.A.,
Devereux,
H.L.,
Clewley,
G.,
...

The effect of cytomegalovirus (CMV) seropositivity on the course of human immunodeficiency virus (HIV) type 1 RNA levels and HIV disease progression was assessed in a cohort of 109 hemophilic men...

Two decades of HIV infection in a cohort of haemophilic individuals: clinical outcomes and response to highly active antiretroviral therapy (2000)

Sabin,
C.A.,
Yee,
T.T.,
Devereux,
H.,
...

OBJECTIVES: Many haemophilic individuals infected with HIV died before receiving antiretroviral therapy (ART). Most who remain alive are chronically infected with hepatitis C virus (HCV), which has...

Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS (2000)

Vanhems,
P.,
Hirschel,
B.,
Phillips,
A.N.,
...

The severity and the duration of acute human immunodeficiency virus (HIV) infection (AHI) are associated with a faster rate of progression to AIDS, but the prognostic value of the length of...

Prognostic value of single measurements of beta-2-microglobulin, immunoglobulin A in HIV disease after controlling for CD4 lymphocyte counts and plasma HIV RNA levels (2000)

Ullum,
H.,
Cozzi-Lepri,
A.,
Katzenstein,
T.L.,
...

The interrelationships between the CD4 lymphocyte count, plasma viral load [human immunodeficiency virus (HIV) RNA], beta-2-microglobulin (beta2-M) and immunoglobulin A (IgA) and the mortality risk...

Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens (2000)

Youle,
M.,
Janossy,
G.,
Turnbull,
W.,
...

OBJECTIVE: To describe the short-term changes in CD4 lymphocyte counts after the interruption of antiretroviral HIV therapy in order to increase the understanding of CD4 lymphocyte dynamics, and so...

Changes in CD4 lymphocyte counts after interruption of therapy in patients with viral failure on protease inhibitor-containing regimens (2000)

Youle,
M.,
Janossy,
G.,
Turnbull,
W.,
...

OBJECTIVE: To describe the short-term changes in CD4 lymphocyte counts after the interruption of antiretroviral HIV therapy in order to increase the understanding of CD4 lymphocyte dynamics, and so...

Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection. I.CO.N.A. Study Group (2000)

Rezza,
G.,
Cozzi-Lepri,
A.,
D'Arminio Monforte,
A.,
...

CONTEXT: According to recent studies, women have lower plasma HIV RNA concentrations than men. However, these studies did not take into account the duration of HIV infection. OBJECTIVES: To analyze...

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population (2000)

Mocroft,
A.,
Devereux,
H.,
Kinloch-de-Loes,
S.,
...

BACKGROUND: Highly active antiretroviral therapy (HAART) is now widely used in clinical practice and gives rise to a range of immunological, virological and clinical responses. OBJECTIVES: To...

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population (2000)

Mocroft,
A.,
Devereux,
H.,
Kinloch-de-Loes,
S.,
...

BACKGROUND: Highly active antiretroviral therapy (HAART) is now widely used in clinical practice and gives rise to a range of immunological, virological and clinical responses. OBJECTIVES: To...

The impact of protease inhibitor-containing highly active antiretroviral therapy on progression of HIV disease and its relationship to CD4 and viral load (2000)

Miller,
V.,
Sabin,
C.A.,
Phillips,
A.N.,
...

OBJECTIVE: To compare the rate of disease progression according to viral load and CD4 cell count in patients receiving or not receiving highly active antiretroviral therapy (HAART), defined as...

The influence of gender, social circumstances and smoking on survival: the Renfrew and Paisley study (2000)

Marang-van De Mheen,
P.J.,
Smith,
G.D.,
Hart,
C.L.,
...

The present study aimed to compare survival to age 75 between men and women, by social circumstances and smoking behaviour. A 20 year follow up was carried out of a large representative cohort of...

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naive Patients (2000)

D'Arminio Monforte,
A.,
Cozzi-Lepri,
A.,
Rezza,
G.,
...

OBJECTIVE: To evaluate the frequency of discontinuation of the first highly active antiretroviral regimen (HAART) and the factors predictive of discontinuing for toxicity and failure in a...

Resistance profiles in patients with viral rebound on potent antiretroviral therapy (2000)

Cozzi-Lepri,
A.,
Sabin,
C.A.,
Staszewski,
S.,
...

The prevalence of phenotypic drug resistance was assessed in 60 patients with a viral rebound after they received a protease inhibitor (PI)- or nonnucleoside reverse transcriptase inhibitor (NNRTI)-...

Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population. Royal Free Centre for HIV Medicine (2000)

Mocroft,
A.,
Devereux,
H.,
Kinloch-de-Loes,
S.,
...

BACKGROUND: Highly active antiretroviral therapy (HAART) is now widely used in clinical practice and gives rise to a range of immunological, virological and clinical responses. OBJECTIVES: To...

Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? (2000)

Mocroft,
A.,
Gill,
M.J.,
Davidson,
W.,
...

OBJECTIVES: To describe gender differences in starting and response to treatment regimens and long-term clinical outcome in a well- characterized regional population from the Southern Alberta HIV...

Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected patients after the introduction of highly active antiretroviral therapy. EuroSIDA Study Group JD (2000)

Kirk,
O.,
Gatell,
J.M.,
Mocroft,
A.,
...

The impact of highly active antiretroviral therapy (HAART) among human immunodeficiency virus (HIV)-infected patients on the incidences of mycobacterial infections has not been studied in detail. We...

Familial craniofacial fibrous dysplasia: absence of linkage to GNAS1 and the gene for cherubism. (2000)

Mangion,
J.,
Edkins,
S.,
Goss,
A.N.,
...

Regulation of apoptosis and replicative senescence in CD8+ T cell following acute viral infection (2000)

Plunkett,
F.J.,
Soares,
M.V.D.,
Salmon,
M.,
...

Viral infections are characterised by a large expansion of CD8+ effector T cells. Once generated, these T cells must be cleared and homeostasis re-established. In this review we describe two...

Femoral atherosclerosis in an older British population: prevalence and risk factors (2000)

Leng,
G.C.,
Papacosta,
O.,
Whincup,
P.,
...

Most estimates of the prevalence of peripheral atherosclerosis have been based on intermittent claudication or lower limb blood flow. The aim of this study was therefore to determine the prevalence...

Aiaa 98--0879 (1999)

6> Re s Reynolds number based on length s T Temperature, K V Velocity, m/s x; y; z Cartesian body axes, m Angle of attack, deg Wall-normal distance, m Density, kg/m 3 Subscripts tran Transition w...

In vivo HIV-1 replicative capacity in early and advanced infection (1999)

Phillips,
A.N.,
McLean,
A.R.,
Loveday,
C.,
...

Risk of cancer in patients with HIV disease. London African HIV/AIDS Study Group (1999)

Petruckevitch,
A.,
Del Amo,
J.,
Phillips,
A.N.,
...

Risk factors for tuberculosis in patients with AIDS in London: a case-control study (1999)

Del Amo,
J.,
Petruckevitch,
A.,
Phillips,
A.N.,
...

How soon after HIV seroconversion is antiretroviral therapy initiated? (1999)

The UK Register Of HIV Seroconverters Steering Committee,
Phillips,
A.N.,
Johnson,
A.M.

Immune markers and viral load after HIV-1 seroconversion as predictors of disease progression in a cohort of haemophilic men (1998)

Sabin,
C.A.,
Devereux,
H.,
Phillips,
A.N.,
...

Disease progression and survival in HIV-1-infected Africans in London (1998)

Del Amo,
J.,
Petruckevitch,
A.,
Phillips,
A.N.,
...

Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London (1998)

Petruckevitch,
A.,
Del Amo,
J.,
Phillips,
A.N.,
...

Demographic, clinical and social factors associated with human immunodeficiency virus infection and other sexually transmitted diseases in a cohort of women from the United Kingdom and Ireland. MRC Collaborative Study of women with HIV (1998)

Madge,
S.,
Phillips,
A.N.,
Griffioen,
A.,
...

Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases (1998)

McNair,
A.N.,
Moloney,
M.,
Portmann,
B.C.,
...

The `crckapb' Latex Style File: Instructions For Authors (1997)

A. N.

If you want to make an abstract, you can use the abstract environment which is standard L a T E X. You need not enter the word `Abstract'. 5. Headings Please distinguish the following four levels of...

Investigating temporal changes in the rate of HIV progression: challenges and limitations (1997)